April 13, 2022
Back

Former Pfizer Exec Takes Legal Reins at Needle-Free Vaccine Company - Law.com International

Dan Devine, chief business officer and general counsel of Vaxxas. Courtesy photo

Australia- and U.S.-based biotechnology company Vaxxas, which is seeking to commercialize a needle-free vaccination technology, has added Dan Devine as chief business officer and general counsel.

Devine started his career at the Wall Street law firm Dewey Ballantine before spending more than two decades in the biopharmaceutical industry, including a stint at Pfizer, where he headed an international business development group. He also founded, led and took public Patrys, a Melbourne-based developer of anti-cancer antibodies.

This premium content is reserved exclusively for International Edition subscribers.

Benefits of a subscription include:

  • Customized news by region including UK, Asia, Europe, Latin America, Middle East, Africa, and North America
  • Cutting-edge research such as UK Top 100, China 45, and Asia 50
  • Get the inside track on the biggest breaking stories that delve deep into the issues behind the headlines
  • Comprehensive coverage of the dynamic legal market from people moves to the major international jurisdictions
  • Global view into how legal tech, business of law, in-house and regulatory environments are intersecting worldwide

Questions about group subscriptions? Contact an Account Specialist [email protected] | +1-855-808-4530 (Americas) | +44(0) 800 098 86009 (UK & Europe)



source: https://www.law.com/international-edition/2022/04/13/former-pfizer-exec-takes-legal-reins-at-needle-free-vaccine-company/

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.